Literature DB >> 4658852

Inhibition of human serum dopamine -hydroxylase after the oral administration of fusaric acid.

T Nagatsu, T Kato, H Kuzuya, T Okada, H Umezawa, T Takeuchi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4658852     DOI: 10.1007/bf01923125

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  8 in total

1.  Development of a strain of spontaneously hypertensive rats.

Authors:  K OKAMOTO; K AOKI
Journal:  Jpn Circ J       Date:  1963-03

2.  Serum dopamine-beta-hydroxylase activity.

Authors:  R Weinshilboum; J Axelrod
Journal:  Circ Res       Date:  1971-03       Impact factor: 17.367

3.  Adrenal tyrosine hydroxylase and dopamine beta-hydroxylase in spontaneously hypertensive rats.

Authors:  I Nagatsu; T Nagatsu; K Mizutani; H Umezawa; M Matsuzaki; T Takeuchi
Journal:  Nature       Date:  1971-04-09       Impact factor: 49.962

4.  Purification and properties of bovine phenylethanolamine N-methyltransferase.

Authors:  R J Connett; N Kirshner
Journal:  J Biol Chem       Date:  1970-01-25       Impact factor: 5.157

5.  Fusaric acid, a hypotensive agent produced by fungi.

Authors:  H Hidaka; T Nagatsu; K Takeya; T Takeuchi; H Suda
Journal:  J Antibiot (Tokyo)       Date:  1969-05       Impact factor: 2.649

6.  An assay for dopamine-beta-hydroxylase activity in tissues and serum.

Authors:  M Goldstein; L S Freedman; M Bonnay
Journal:  Experientia       Date:  1971-06

7.  Inhibition of dopamine beta-hydroxylase by fusaric acid (5-butylpicolinic acid) in vitro and in vivo.

Authors:  T Nagatsu; H Hidaka; H Kuzuya; K Takeya; H Umezawa
Journal:  Biochem Pharmacol       Date:  1970-01       Impact factor: 5.858

8.  The clinical trial of a new hypotensive agent, "fusaric acid (5-butylpicolinic acid)": the preliminary report.

Authors:  F Terasawa; M Kameyama
Journal:  Jpn Circ J       Date:  1971-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.